Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Doc Ophthalmol ; 136(3): 177-189, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29766345

RESUMEN

PURPOSE: To investigate the contribution of full-field transient pattern-reversal visually evoked potentials (PRVEP) on cross-sectional evaluations of visual function in patients with and without neurofibromatosis type 1 (NF1) affected by optic pathway low-grade gliomas (OPLGG). METHODS: Participants were children and adolescents referred for visual function evaluation and receiving treatment for OPLGG, linked (NF1-OPLGG) or not to NF1 (Non-NF1-OPLGG). An age-adjusted control group was included for comparison. Monocular full-field PRVEPs were recorded from each eye in accordance with ISCEV standards. Parameters of peak-to-peak P100 amplitude (µV) and P100 peak time (ms) were measured. Cutoff normative values obtained from controls for 15' and 60' check sizes were ≥ 9.0 µV for N75-P100 amplitude and ≤ 103.0 ms for P100 peak time. The association of age, gender, tumor resection and NF1 with P100 amplitude reduction and P100 peak time delay was explored by Firth logistic regression modeling. RESULTS: Participants were 30 patients (15 males, 60% Non-NF1) with ages from 3.6 to 19.9 years (mean ± SD = 9.2 ± 3.8 years; median = 8.4 years) and 19 controls (12 males) with ages from 3.7 to 19.9 years (mean ± SD = 10.4 ± 4.9 years; median = 9.5 years). Overall, 68% of tested eyes presented reduced P100 amplitudes for both check sizes (46% in the NF-1 and 83% in the Non-NF1) and delayed P100 for both check sizes (38% in NF1 and 89% in Non-NF1). Absence of NF1 adjusted for age, gender and tumor resection was significantly associated with marginally reduced P100 amplitude for 15' checks [odds ratio (OR): 6.26; 95% confidence interval (CI) = 0.96-40.94; p = 0.055]. CONCLUSIONS: Full-field PRVEP on cross-sectional evaluations contributed to detect visual dysfunction in two-thirds of patients with OPLGG by highlighting subclinical evidence of visual loss. Abnormalities were more frequent and more severe in OPLGG not linked to NF1 than in NF1-OPLGG; however, there was a difference in surgical management between these groups. PRVEP parameters may provide reliable evidence of visual pathway involvement in OPLGG, helping to hasten treatment before optic atrophy is detected.


Asunto(s)
Potenciales Evocados Visuales/fisiología , Neurofibromatosis 1/fisiopatología , Glioma del Nervio Óptico/fisiopatología , Trastornos de la Visión/fisiopatología , Agudeza Visual/fisiología , Vías Visuales/fisiopatología , Adolescente , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Masculino , Neurofibromatosis 1/diagnóstico , Glioma del Nervio Óptico/diagnóstico , Pruebas de Visión , Adulto Joven
2.
Doc Ophthalmol ; 135(1): 53-67, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28560498

RESUMEN

PURPOSE: To determine gender-based normative values for pattern-reversal (PR) and flash (F) visually evoked potentials (VEP) under binocular and monocular stimulation in healthy adults. METHODS: Healthy adults (age ≥18 years) were recruited among university employees and students. Inclusion criteria were absence of abnormalities in fundoscopy, tracking ability, stereopsis and pupillary reflexes; best-corrected visual acuity ≤.00 logMAR; and refractive error (spherical equivalent) from -6.00 to +6.00. Exclusion criteria were previous intraocular surgery, systemic and/or neurological disorders. Binocular and monocular tests were performed according to International Society for Clinical Electrophysiology of Vision standards for PRVEP (reversal rate = 1.9 Hz, checkerboard stimuli 15' and 60' at 100% contrast) and FVEP (3 cd s/m2, rate = 1 Hz). VEP parameters of amplitude (µV) and peak times (ms) were measured. Inter-ocular differences, inter-peak intervals (N135-N75) and binocular summation were determined. RESULTS: Fifty-four subjects (28 females; mean age = 40.4 ± 13.7 years; median = 40.0 years) were included. Mean P100 latencies for 15' and 60' stimuli were, respectively, 94.6 ± 4.7 ms and 96.1 ± 4.2 for women. Mean values of P100 latency for men were 97.4 ± 4.9 for 15' and 97.7 ± 4.2 for 60' stimuli. Larger mean P100 for 15' checks was observed in women (12.8 ± 5.7 µV) than men (8.6 ± 2.5 µV) in PRVEP. Similar results were found for FVEP N2-P2 amplitudes (mean = 14.6 ± 4.9 for women and 9.8 ± 4.0 for men). CONCLUSIONS: Gender-based normative values for PRVEP and FVEP were determined, with women disclosing higher responses than men for smaller stimuli in the visual pathway. The use of gender-based normative values in the analysis of clinical VEP data for diagnostic and therapeutic purposes is recommendable. Additional analysis including inter-peak intervals and binocular summation ratio might improve the diagnostic power of VEP.


Asunto(s)
Potenciales Evocados Visuales/fisiología , Visión Binocular/fisiología , Adolescente , Adulto , Anciano , Estudios Transversales , Femenino , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Estimulación Luminosa , Valores de Referencia , Factores Sexuales , Visión Monocular/fisiología , Agudeza Visual/fisiología , Adulto Joven
3.
Eur J Ophthalmol ; 31(3): 1351-1360, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-32468859

RESUMEN

PURPOSE: The purpose of this study was to assess visual function by visually evoked potentials in adults with orbital and other primary brain tumors affecting the optic pathway. METHODS: In this retrospective case-control series, patients with orbital (intraconal and extraconal) or midline/chiasmatic tumors were included. Visually evoked potentials using pattern-reversal visually evoked potential and flash visually evoked potential stimuli were performed according to the international standards. Outcome measures were visually evoked potential parameters of amplitude (µV) and peak times (ms) measured both for the P100 component (pattern-reversal visually evoked potentials) and the N2P2 complex (flash visually evoked potential). Individual results were also compared with gender-based normative values. RESULTS: A group of 21 adult patients (17 females) and age- and sex-matched controls were evaluated. Tumor location was intraconal (6 meningiomas, 3 hemangiomas, 1 glioma), extraconal (6 meningiomas), and midline (3 pituitary adenomas, 2 hypothalamic/chiasmatic low-grade gliomas). Abnormal fundus (76%), abnormal pupillary reflexes (71%), reduced visual acuity (62%), strabismus (48%), and proptosis (38%) were present. Visually evoked potential abnormalities were found in at least one eye of all cases. Affected eyes had significantly reduced amplitudes and prolonged peak times for pattern-reversal visually evoked potentials (p < .001) and significantly reduced amplitudes for flash visually evoked potential (p < .001). In unilateral orbital tumors, abnormally prolonged pattern-reversal visually evoked potential peak times were also detected in some contralateral eyes (n = 6/16). CONCLUSION: Visually evoked potential abnormalities were found in all adult patients with orbital and other intracranial primary tumors, even in eyes with normal exam and good visual acuity. Visually evoked potential can be used as a non-invasive ancillary test to characterize and monitor visual function in subjects with these neoplastic lesions.


Asunto(s)
Neoplasias Encefálicas , Potenciales Evocados Visuales , Adulto , Potenciales Evocados , Femenino , Humanos , Estudios Retrospectivos , Visión Ocular
4.
Arq Bras Oftalmol ; 84(2): 140-148, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33567011

RESUMEN

PURPOSE: To determine visual impairment due to optic pathway tumors in children unable to perform recognition acuity tests. METHODS: Grating visual acuity scores, in logMAR, were obtained by sweep visually evoked potentials (SVEP) in children with optic pathway tumors. The binocular grating visual acuity deficit was calculated by comparison with age-based norms and then assigned to categories of visual impairment as mild (from 0.10 to 0.39 logMAR), moderate (from 0.40 to 0.79 logMAR), or severe (≥0.80 logMAR). Interocular differences were calculated by subtraction and considered increased if >0.10 logMAR. RESULTS: The participants were 25 children (13 boys; mean ± SD age, 35.1 ± 25.9 months; median age, 32.0 months) with optic pathway tumors (24 gliomas and 1 embryonal tumor), mostly located at the hypothalamic-chiasmatic transition (n=21; 84.0%) with visual abnormalities reported by parents (n=17; 68.0%). The mean grating acuity deficit was 0.60 ± 0.36 logMAR (median, 0.56 logMAR). Visual impairment was detected in all cases and was classified as mild in 10 (40.0%), moderate in 8 (32.0%), and severe in 7 (28.0%) children, along with increased interocular differences (>0.1 logMAR) (n=16; 64.0%). The remarkable ophthalmological abnormalities were nystagmus (n=17; 68.0%), optic disc cupping and/or pallor (n=13; 52.0%), strabismus (n=12; 48.0%), and poor visual behavior (n=9; 36.0%). CONCLUSION: In children with optic pathway tumors who were unable to perform recognition acuity tests, it was possible to quantify visual impairment by sweep-visually evoked potentials and to evaluate interocular differences in acuity. The severity of age-based grating visual acuity deficit and interocular differences was in accordance with ophthalmological abnormalities and neuroimaging results. Grating visual acuity deficit is useful for characterizing visual status in children with optic pathway tumors and for supporting neuro-oncologic management.


Asunto(s)
Neoplasias , Baja Visión , Adolescente , Adulto , Niño , Potenciales Evocados , Potenciales Evocados Visuales , Humanos , Masculino , Persona de Mediana Edad , Agudeza Visual , Adulto Joven
5.
Arq Bras Oftalmol ; 70(4): 713-7, 2007.
Artículo en Portugués | MEDLINE | ID: mdl-17906773

RESUMEN

PURPOSE: To describe the main intervening factors observed during the acquisition and analysis of multifocal electroretinogram (mfERG), that could affect the recorded signal, the obtained responses and their analysis. METHODS: The error factors observed during the acquisition of 100 sequential multifocal electroretinogram tests, in the period of May to July, 2005 were analyzed. The examinations of multifocal electroretinogram were carried out in agreement with international guideline recommendations, taking into account the established parameters of equipment, with 61 elements, and visual angle of 30 degrees. All patients had been submitted to complete ophthalmologic examination, excluding those with inadequate transparency of ways, flat corneas and those incapable to visualize a central fixation target. RESULTS: The intervening factors, that could cause artifacts and errors in the interpretation of the obtained results, observed and corrected during the acquisition of multifocal electroretinogram were: eccentric or poor fixation, eye movements, orbicular contraction, cervical muscle contraction, inadequate transparency of the corneal electrode, electrode displacement, lens support decentralization, inadequate viewing distance in patients with high refractive errors, eye height inadequacy in relation to the center of the screen, electrical noise in 60 HZ frequency and electromagnetic field and high impedances. Excessive use of filters in wave processing for noise and artifact removal can interfere with the analysis of the obtained results. CONCLUSION: Simple observational cares during signal acquisition are of significant importance to ensure accuracy of the topographical electroretinogram information, good waveform morphology and low noise level register. Through their ready correction, the correct and adjusted analysis of the amplitude and of implicit time of peaks N1, P1 and N2 is reliable. Digital smooth system with specific frequency peak removal supply waves with more defined morphology with lower amplitude reduction than other available resources.


Asunto(s)
Electrorretinografía/métodos , Electrorretinografía/instrumentación , Movimientos Oculares/fisiología , Fijación Ocular/fisiología , Humanos
6.
Arq. bras. oftalmol ; Arq. bras. oftalmol;84(2): 140-148, Mar,-Apr. 2021. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1153128

RESUMEN

ABSTRACT Purpose: To determine visual impairment due to optic pathway tumors in children unable to perform recognition acuity tests. Methods: Grating visual acuity scores, in logMAR, were obtained by sweep visually evoked potentials (SVEP) in children with optic pathway tumors. The binocular grating visual acuity deficit was calculated by comparison with age-based norms and then assigned to categories of visual impairment as mild (from 0.10 to 0.39 logMAR), moderate (from 0.40 to 0.79 logMAR), or severe (≥0.80 logMAR). Interocular differences were calculated by subtraction and considered increased if >0.10 logMAR. Results: The participants were 25 children (13 boys; mean ± SD age, 35.1 ± 25.9 months; median age, 32.0 months) with optic pathway tumors (24 gliomas and 1 embryonal tumor), mostly located at the hypothalamic-chiasmatic transition (n=21; 84.0%) with visual abnormalities reported by parents (n=17; 68.0%). The mean grating acuity deficit was 0.60 ± 0.36 logMAR (median, 0.56 logMAR). Visual impairment was detected in all cases and was classified as mild in 10 (40.0%), moderate in 8 (32.0%), and severe in 7 (28.0%) children, along with increased interocular differences (>0.1 logMAR) (n=16; 64.0%). The remarkable ophthalmological abnormalities were nystagmus (n=17; 68.0%), optic disc cupping and/or pallor (n=13; 52.0%), strabismus (n=12; 48.0%), and poor visual behavior (n=9; 36.0%). Conclusion: In children with optic pathway tumors who were unable to perform recognition acuity tests, it was possible to quantify visual impairment by sweep-visually evoked potentials and to evaluate interocular differences in acuity. The severity of age-based grating visual acuity deficit and interocular differences was in accordance with ophthalmological abnormalities and neuroimaging results. Grating visual acuity deficit is useful for characterizing visual status in children with optic pathway tumors and for supporting neuro-oncologic management.(AU)


RESUMO Objetivo: Determinar o grau de deficiência visual em crianças com tumores da via óptica incapazes de informar a acuidade visual de reconhecimento. Método: A acuidade visual de grades, em logMAR, foi estimada por potenciais visuais evocados de varredura em crianças com tumores das vias ópticas. O déficit da acuidade visual de grades binocular foi calculado em relação ao valor mediano normativo esperado para a idade e a deficiência visual, classificada como leve (0,10 a 0,39 logMAR), moderada (0,40 a 0,79 logMAR) ou grave (≥0,80 logMAR). Diferenças inter-oculares foram calculadas por subtração e consideradas aumentadas se >0,10 logMAR. Resultados: Foram avaliadas 25 crianças (13 meninos; média de idade ± DP=35,1± 25,9 meses; mediana=32,0 meses) com tumores da via óptica (24 gliomas e 1 tumor embrionário) localizados particularmente na transição hipotalâmico-quiasmática (n=21; 84,0%) e com anormalidades visuais detectadas pelos pais (n=17; 68,0%). A média do déficit da acuidade de grades foi 0,60 ± 0,36 logMAR (mediana=0,56 logMAR). Observou-se deficiência visual leve em 10 (40,0%), moderada em 8 (32,0%) e grave em 7 (28,0%), além de aumento da diferença interocular da acuidade visual (n=16; 64,0%). As principais alterações oftalmológicas encontradas foram: nistagmo (n=17; 68,0%), aumento da escavação do disco óptico e/ou palidez (n=13; 52,0%), estrabismo (n=12; 48,0%) e comportamento visual pobre (n=9; 36,0%). Conclusão: Em crianças com tumor da via óptica e incapazes de responder aos testes de acuidade visual de reconhecimento, foi possível quantificar deficiência visual por meio dos potenciais visuais evocados de varredura e avaliar a diferença interocular da acuidade visual de grades. A gravidade do déficit da acuidade visual de grades relacionado à idade e a diferença interocular da acuidade visual de grades foram congruentes com alterações oftalmológicas e neuroimagem. O déficit da acuidade visual de grades foi útil à caracterização do estado visual em crianças com tumores da via óptica e ao embasamento da assistência neuro-oncológica.(AU)


Asunto(s)
Humanos , Niño , Vías Visuales/patología , Agudeza Visual , Glioma del Nervio Óptico/patología , Trastornos de la Visión/etiología , Potenciales Evocados Visuales
8.
Arq. bras. oftalmol ; Arq. bras. oftalmol;70(4): 713-717, jul.-ago. 2007. ilus, tab
Artículo en Portugués | LILACS | ID: lil-461966

RESUMEN

OBJETIVO: Descrever os principais fatores intervenientes observados durante a aquisição e análise do exame de eletrorretinograma multifocal (ERGmf), que afetam o registro gráfico das ondas obtidas e portanto sua análise. MÉTODOS: Análise dos fatores de erro observados durante a aquisição de 100 exames seqüenciais de eletrorretinograma multifocal, realizados com o Reti System da Roland Consult, no período de maio a julho de 2005. Os exames de eletrorretinograma multifocal foram realizados conforme recomendações internacionais, respeitando-se os parâmetros preestabelecidos do equipamento, com 61 elementos, e ângulo visual de 30°. Todos os pacientes foram submetidos à avaliação oftalmológica completa, excluindo-se aqueles com transparência inadequada de meios, córneas planas e os incapazes de visualizar as linhas de fixação. RESULTADOS: Os fatores intervenientes, que poderiam causar erros na interpretação dos resultados obtidos, observados e corrigidos durante a realização dos exames foram: fixação excêntrica, movimentação dos olhos, contração do orbicular, contração da musculatura cervical, não-correção adequada, não-transparência adequada do eletrodo corneano, deslocamento do eletrodo em geral para baixo, descentralização do suporte da lente corretora, distância inadequada paciente-monitor em pacientes com alta ametropia, altura inadequada dos olhos em relação ao centro da tela, ruído na freqüência de 60 HZ (rede elétrica) e de campo eletromagnético, impedâncias elevadas. No processamento das ondas, a utilização excessiva de filtros para remoção de ruídos dos registros obtidos, pode interferir na análise dos resultados obtidos. CONCLUSÕES: Cuidados simplesmente observacionais durante a aquisição dos sinais são de importância significativa para a obtenção de registros com boa morfologia e baixo nível de ruído. Permitindo, por meio de sua pronta correção, a análise correta e adequada da amplitude e do tempo implícito dos picos N1 e P1, fundamentais...


PURPOSE: To describe the main intervening factors observed during the acquisition and analysis of multifocal electroretinogram (mfERG), that could affect the recorded signal, the obtained responses and their analysis. METHODS: The error factors observed during the acquisition of 100 sequential multifocal electroretinogram tests, in the period of May to July, 2005 were analyzed. The examinations of multifocal electroretinogram were carried out in agreement with international guideline recommendations, taking into account the established parameters of equipment, with 61 elements, and visual angle of 30°. All patients had been submitted to complete ophthalmologic examination, excluding those with inadequate transparency of ways, flat corneas and those incapable to visualize a central fixation target. RESULTS: The intervening factors, that could cause artifacts and errors in the interpretation of the obtained results, observed and corrected during the acquisition of multifocal electroretinogram were: eccentric or poor fixation, eye movements, orbicular contraction, cervical muscle contraction, inadequate transparency of the corneal electrode, electrode displacement, lens support decentralization, inadequate viewing distance in patients with high refractive errors, eye height inadequacy in relation to the center of the screen, electrical noise in 60 HZ frequency and electromagnetic field and high impedances. Excessive use of filters in wave processing for noise and artifact removal can interfere with the analysis of the obtained results. CONCLUSION: Simple observational cares during signal acquisition are of significant importance to ensure accuracy of the topographical electroretinogram information, good waveform morphology and low noise level register. Through their ready correction, the correct and adjusted analysis of the amplitude and of implicit time of peaks N1, P1 and N2 is reliable. Digital smooth system with specific frequency peak...


Asunto(s)
Humanos , Electrorretinografía/métodos , Electrorretinografía/instrumentación , Movimientos Oculares/fisiología , Fijación Ocular/fisiología
9.
An. bras. dermatol ; An. bras. dermatol;80(supl.3): S275-S282, nov.-dez. 2005. ilus, tab
Artículo en Portugués | LILACS | ID: lil-459417

RESUMEN

FUNDAMENTOS: A ocorrência de retinopatia pela cloroquina vem diminuindo em todo o mundo, com poucos estudos brasileiros sobre o problema. OBJETIVOS: Compreender melhor a fisiopatologia das reações tipo 1. MÉTODOS: Foram revisados os prontuários e analisadas a relação entre efeitos adversos e a dose diária/peso; a idade e o diagnóstico clínico; e a peridiocidade do controle oftalmológico. RESULTADOS: 35,7 por cento de efeitos adversos: alterações oculares (17,4 por cento): pigmentação retiniana sugestiva de retinopatia antimalárica (12 por cento), depósitos corneanos (3,1 por cento), cefaléia (2,9 por cento) e sintomas visuais agudos (2,3 por cento), gastrointestinais (10 por cento), dermatológicos (3,4 por cento), neuromusculares (1,7 por cento) e psiquiátricos (0,3 por cento). Retinopatia antimalárica confirmada (2,6 por cento). Não houve associação estatisticamente significativa entre a ocorrência de efeitos adversos e alterações retinianas com a dose diária por peso nem com o tipo clínico de lúpus eritematoso. Alterações retinianas foram estatisticamente significativas (p=0.004) nos pacientes acima de 50 anos. Controle oftalmológico com intervalo médio de 10,5 meses. CONCLUSÕES: A retinopatia antimalárica ocorreu em 2,6 por cento dos pacientes. O controle oftalmológico exigiu maior cuidado nos pacientes acima de 50 anos pela dificuldade entre a diferenciação das alterações iniciais da retinopatia antimalárica e da degeneração macular senil.


BACKGROUND: The occurrence of antimalarial retinopathy is reducing all over the world, but are few brazilian studies. OBJECTIVES: Analysis of the occurrence of adverse effects, triggered by use of 250mg/d of chloroquine diphosphate in 350 patients with for lupus erythematosus. METHODS: Review of clinical records and analysis between adverse effects and the daily dose per kg, age and the differents types of lupus erythematosus; and the periodicity of ophthalmologic screening. RESULTS: 35,7 percent of adverse effects, ocular toxicity (17,4 percent): retinal pigmentation suggestive of antimalarial retinopathy (12 percent), corneal deposits (3,1 percent) and acute visual symptoms(2,3 percent); gastrointestinal (10 percent), cutaneous (3,4 percent), headache (2,9 percent), neuromuscular (1,7 percent) and psychiatric (0,3 percent). Antimalarial retinopathy confirmed in 2,6 percent. No statistically significant association between occurrence of adverse effects and retinotoxicity with the daily dose per kg and the type of lupus erythematosus. Retinotoxicity was statistically significant (p=0,004) in patients over 50 years. Ophthalmologic screening was conducted on average after 10,5 months. CONCLUSIONS: Antimalarial retinopathy occurred in 2,6 percent of the patients. Ophthalmologic screening had to be more careful in patients over 50 years because the difficulty to differentiate between initial antimalarial retinopathy and senile macular degeneration.

10.
Arq. bras. oftalmol ; Arq. bras. oftalmol;68(4): 543-546, jul.-ago. 2005. ilus
Artículo en Portugués | LILACS | ID: lil-417798

RESUMEN

Os autores descrevem um caso de endoftalmite endógena por Candida albicans, em recém-nascido prematuro, refratária ao tratamento com anfotericina B endovenosa e que apresentou resolução com o uso do fluconazol endovenoso. Ressaltam ainda os aspectos clínicos da endoftalmite endógena por Candida albicans por meio de revisão da literatura.


Asunto(s)
Humanos , Masculino , Recién Nacido , Antifúngicos/uso terapéutico , Candidiasis/tratamiento farmacológico , Endoftalmitis/tratamiento farmacológico , Fluconazol/uso terapéutico , Anfotericina B/uso terapéutico , Candidiasis/complicaciones , Endoftalmitis/microbiología , Endoftalmitis , Recien Nacido Prematuro , Inyecciones Intravenosas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA